Design Therapeutics, Inc.DSGNNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank33
3Y CAGR-13.4%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-13.4%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$212.50M-12.2%
2024$242.10M-12.8%
2023$277.69M-15.2%
2022$327.31M-14.3%
2021$382.13M+3477.2%
2020$-11.31M-210.7%
2019$-3.64M-